Penn Vet | Clinical Trial Detail - Clinical trial for dogs with atrial fibrillation
New Bolton Center Kennett Square, PA
Emergencies & Appointments:
Ryan Hospital Philadelphia, PA

Clinical trial for dogs with atrial fibrillation

Feb 15, 2018

Atrial fibrillation is a type of cardiac arrhythmia (abnormal heart rhythm). Dogs with atrial fibrillation typically have a very fast heart rate that causes weakness, exercise intolerance, and eventually congestive heart failure. Treatments to slow down the heart rate improve a dog’s day to day quality of life. The goal of this study is to determine whether slowing down the heart rate also results in improved survival.

The study involves 4 to 5 visits to Penn Vet over the course of one year.


Atrial fibrillation
No prior treatment with doxorubicin


  • Eligible dogs receive a discount for the cardiac evaluations performed at each study visit:
    • Study covers 60% of echocardiogram fees
    • Study covers 100% of ECG and 24-hour Holter monitoring fees
    • Study covers 100% of cardiac biomarker blood test fees
  • Clients are responsible for all other costs including physical examination, blood tests (apart from cardiac biomarkers), and other diagnostic tests (if recommended).
  • Clients are responsible for the cost of all medications, including recommended heart medications.

Contact: Dr. Anna Gelzer